Literature DB >> 7008091

Albumins stabilize prostaglandin I2.

M A Wynalda, F A Fitzpatrick.   

Abstract

We monitored the chemical stability of prostaglandin I2 in the presence of different plasma proteins. PGI2 hydrolyzes by first order reaction kinetics, dependent on the albumin concentration in aqueous buffers. Chemical analysis shows that vertebrate albumins prolong the half-life of prostaglandin I2. The degree of stabilization varies quantitatively among different species. The results indicate that prostaglandin I2 may persist in its active form longer than previously supposed in some experimental conditions.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7008091     DOI: 10.1016/0090-6980(80)90138-0

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  7 in total

1.  Structural insights into human serum albumin-mediated prostaglandin catalysis.

Authors:  Jinsheng Yang; Charles E Petersen; Chung-Eun Ha; Nadhipuram V Bhagavan
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

2.  Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I.

Authors:  Y Yui; T Aoyama; H Morishita; M Takahashi; Y Takatsu; C Kawai
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

3.  Prostacyclin increases filterability of normal and rigidified human red blood cells in vitro.

Authors:  I B Kovacs; J O'Grady
Journal:  Agents Actions       Date:  1984-02

4.  Blood plasma influences anti-aggregatory potency of prostaglandins: effect of albumin.

Authors:  G Kobzar; V Mardla; I Järving; N Samel
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 4.473

5.  Comparison of the effect of a conventional heparin and a low molecular weight heparinoid on platelet function.

Authors:  D P Mikhailidis; M A Barradas; A M Mikhailidis; H Magnani; P Dandona
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

6.  Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man.

Authors:  J Nowak; G A FitzGerald
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

7.  Serum prostacyclin binding defects in thrombotic thrombocytopenic purpura.

Authors:  K K Wu; E R Hall; E C Rossi; A C Papp
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.